Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Plast Reconstr Aesthet Surg ; 70(5): 596-605, 2017 May.
Article in English | MEDLINE | ID: mdl-28320625

ABSTRACT

BACKGROUND: Liposuction and subsequent autologous fat grafting have become essential techniques for fat augmentation in plastic surgery. However, standard harvesting techniques that ensure the survival of adipocytes and stromal vascular fraction (SVF) cells and thus preserve the transplanted fat volume are lacking. In particular, the effect of different parameters of the tumescent solution has not been studied in this context. We hypothesized that the osmolality of the tumescent solution could have a significant effect on the survival of adipocytes and SVF cells. METHODS: We developed two distinct in vitro models based on freshly harvested excision fat from patients undergoing surgical treatment. First, we investigated the effect of osmolality by incubating excision fat in different tumescent solutions and analyzed the total cell survival and the differentiation potential of SVF cells. Vital whole-mount staining, isolation yield of SVF cells, clonogenicity, and osteogenic and adipogenic differentiation capacities were analyzed. Second, we addressed the additional effect of mechanical stress by simulating a liposuction on pieces of excision fat after incubation with the tumescent solutions. RESULTS: Osmolality of the tumescent solution by itself did not have a significant effect on adipocyte and SVF viability or SVF differentiation. However, when osmolality was combined with liposuction, a significant trend toward lower viability and more lipid droplets with lower osmolality was observed. Especially, SVF viability was significantly lower after liposuction with a hypotonic (150 mOsm/kg) solution. CONCLUSION: This study demonstrates the considerable effect of osmolality during liposuction and may lead to the development of "cell-protective" tumescent solutions.


Subject(s)
Lipectomy/methods , Tissue and Organ Harvesting/methods , Adipocytes/drug effects , Adipocytes/physiology , Adipocytes/transplantation , Adipose Tissue/transplantation , Analysis of Variance , Cell Differentiation , Cell Survival/physiology , Cells, Cultured , Female , Humans , Hydrogen-Ion Concentration , Hypertonic Solutions/chemistry , Hypertonic Solutions/pharmacology , Hypotonic Solutions/chemistry , Hypotonic Solutions/pharmacology , Isotonic Solutions/chemistry , Isotonic Solutions/pharmacology , Middle Aged , Osmolar Concentration , Stress, Mechanical , Stress, Physiological/physiology , Stromal Cells/physiology , Transplantation, Autologous
2.
Eur Cell Mater ; 31: 236-49, 2016 Apr 10.
Article in English | MEDLINE | ID: mdl-27062725

ABSTRACT

Pericyte recruitment is essential for the stability of newly formed vessels. It was also suggested that pericytes represent common ancestor cells giving rise to mesenchymal stem cells (MSCs) in the adult. Here, we systematically investigated pericytes and MSCs from different human tissues in terms of their angiogenic and multilineage differentiation potential in vitro in order to assess the suitability of the different cell types for the regeneration of vascularised tissues. Magnetic-activated cell sorting (MACS®) was used to enrich CD34-CD146+ pericytes from adipose tissue (AT) and bone marrow (BM). The multilineage potential of pericytes was assessed by testing their capability to differentiate towards osteogenic, adipogenic and chondrogenic lineage in vitro. Pericytes and endothelial cells were co-seeded on Matrigel™ and the formation of tube-like structures was examined to study the angiogenic potential of pericytes. MSCs from AT and BM were used as controls. CD34-CD146+ cells were successfully enriched from AT and BM. Only BM-derived cells exhibited trilineage differentiation potential. AT-derived cells displayed poor chondrogenic differentiation upon stimulation with transforming growth factor-ß1. Interestingly, osteogenic differentiation was more efficient in AT-PC and BM-PC compared to the respective full MSC population. Matrigel™ assays revealed that pericytes from all tissues integrated into tube-like structures. We show that MACS®-enriched pericytes from BM and AT have the potential to regenerate tissues of different mesenchymal lineages and support neovascularisation. MACS® represents a simple enrichment strategy of cells, which is of particular interest for clinical application. Finally, our results suggest that the regenerative potential of pericytes depends on their tissue origin, which is an important consideration for future studies.


Subject(s)
Cell Lineage/physiology , Cell Plasticity/physiology , Mesenchymal Stem Cells/cytology , Neovascularization, Physiologic/physiology , Pericytes/cytology , Adipocytes/cytology , Adipose Tissue/cytology , Antigens, CD34/metabolism , CD146 Antigen/metabolism , Cell Differentiation , Cells, Cultured , Chondrocytes/cytology , Female , Human Umbilical Vein Endothelial Cells/cytology , Humans , Osteocytes/cytology , Pericytes/physiology , Placenta/cytology , Pregnancy , Regeneration/physiology , Retina/cytology
3.
Eur Surg Res ; 49(1): 1-7, 2012.
Article in English | MEDLINE | ID: mdl-22797549

ABSTRACT

Despite the compelling clinical needs in enhancing bone regeneration and the potential offered by the field of tissue engineering, the adoption of cell-based bone graft substitutes in clinical practice is limited to date. In fact, no study has yet convincingly demonstrated reproducible clinical performance of tissue-engineered implants and at least equivalent cost-effectiveness compared to the current treatment standards. Here, we propose and discuss how tissue engineering strategies could be evolved towards more efficient solutions, depicting three different experimental paradigms: (i) bioreactor-based production; (ii) intraoperative manufacturing, and (iii) developmental engineering. The described approaches reflect the need to streamline graft manufacturing processes while maintaining the potency of osteoprogenitors and recapitulating the sequence of biological steps occurring during bone development, including vascularization. The need to combine the assessment of efficacy of the different strategies with the understanding of their mechanisms of action in the target regenerative processes is highlighted. This will be crucial to identify the necessary and sufficient set of signals that need to be delivered at the injury or defect site and should thus form the basis to define release criteria for reproducibly effective engineered bone graft substitutes.


Subject(s)
Bone Transplantation/methods , Tissue Engineering/methods , Animals , Bioreactors , Bone Regeneration , Humans
4.
Eur Cell Mater ; 19: 127-35, 2010 Mar 03.
Article in English | MEDLINE | ID: mdl-20198567

ABSTRACT

Grafts generated by cultivation of progenitor cells from the stromal vascular fraction of human adipose tissue have been proven to have osteogenic and vasculogenic properties in vivo. However, in vitro manufacture of such implants is challenged by complex, impractical and expensive processes, and requires implantation in a separate surgery. This study investigates the feasibility of an intraoperative approach to engineer cell-based bone grafts with tissue harvest, cell isolation, cell seeding onto a scaffold and subsequent implantation within a few hours. Freshly isolated adipose tissue cells from a total of 11 donors, containing variable fractions of mesenchymal and endothelial progenitors, were embedded at different densities in a fibrin hydrogel, which was wrapped around bone substitute materials based on beta-tricalcium phosphate (ChronOS), hydroxyapatite (Engipore), or acellular xenograft (Bio-Oss). The resulting constructs, generated within 3 hours from biopsy harvest, were immediately implanted ectopically in nude mice and analysed after eight weeks. All explants contained blood vessels formed by human endothelial cells, functionally connected to the recipient's vasculature. Human origin cells were also found within osteoid structures, positively immunostained for bone sialoprotein and osteocalcin. However, even with the highest loaded cell densities, no frank bone tissue was detected, independently of the material used. These results provide a proof-of-principle that an intraoperative engineering of autologous cell-based vasculogenic bone substitutes is feasible, but highlight that - in the absence of in vitro commitment--additional cues (e.g., low dose of osteogenic factors or orthotopic environmental conditions) are likely needed to support complete osteoblastic cell differentiation and bone tissue generation.


Subject(s)
Adipose Tissue/transplantation , Bone Substitutes/pharmacology , Bone Transplantation/methods , Stem Cell Transplantation/methods , Stromal Cells/transplantation , Tissue Engineering/methods , Adipose Tissue/cytology , Adipose Tissue/physiology , Animals , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Proliferation/drug effects , Cells, Cultured , Endothelial Cells/cytology , Endothelial Cells/physiology , Endothelial Cells/transplantation , Graft Survival/drug effects , Graft Survival/physiology , Humans , Hydrogels/chemistry , Hydrogels/pharmacology , Intraoperative Period , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/physiology , Mice , Mice, Nude , Neovascularization, Physiologic/drug effects , Neovascularization, Physiologic/physiology , Osteoblasts/cytology , Osteoblasts/drug effects , Osteoblasts/physiology , Osteocalcin/metabolism , Osteogenesis/drug effects , Osteogenesis/physiology , Sialoglycoproteins/metabolism , Stromal Cells/cytology , Stromal Cells/physiology , Transplantation, Heterologous/methods
5.
Ann Rheum Dis ; 67(4): 443-9, 2008 Apr.
Article in English | MEDLINE | ID: mdl-17526552

ABSTRACT

BACKGROUND: Mesenchymal stem cells (MSCs) have a potential immunomodulatory role in autoimmune disease; however, the qualitative properties and haematopoietic support capacity of MSCs derived from patients with autoimmune disease is unclear. OBJECTIVES: To further characterise phenotypically and functionally bone marrow (BM)-derived MSCs from patients with systemic sclerosis (SSc). METHODS: Key parameters of BM-derived MSC function and phenotype were assessed in 12 patients with SSc and compared with 13 healthy normal controls. The parameters included the ability to: form colony-forming unit fibroblasts (CFU-F), differentiate along the adipogenic and osteogenic lineages, express cell surface antigens defining the MSCs population, support normal haematopoiesis and suppress in vitro lymphocyte proliferation induced by either anti-CD3epsilon plus anti-CD28 monoclonal antibodies or the mixed lymphocyte reaction. RESULTS: SSc MSCs were shown to have a similar characteristic phenotype, capacities to form CFU-F and to differentiate along adipogenic and osteogenic lineages as those of healthy donor MSCs. The ability of SSc MSCs to support long-term haematopoiesis was also identical to that of controls. Both healthy donor and SSc BM MSCs reduced the proliferation of autologous and allogeneic peripheral blood mononuclear cells in a cell number dependent fashion. CONCLUSIONS: These results show that BM-derived MSCs from patients with SSc under the described culture conditions exhibit the same phenotypic, proliferative, differentiation potential and immunosuppressive properties as their healthy counterparts and could therefore be considered in an autologous setting. Further studies are needed to ensure the quality and safety of large-scale expansion of patient MSCs prior to their potential use in clinical trials.


Subject(s)
Autoimmune Diseases/immunology , Bone Marrow Cells/immunology , Mesenchymal Stem Cells/immunology , Scleroderma, Systemic/immunology , Adult , Autoimmune Diseases/therapy , Cell Differentiation , Cell Proliferation , Cells, Cultured , Colony-Forming Units Assay , Female , Fibroblasts/pathology , Hematopoiesis , Hematopoietic Stem Cell Transplantation , Humans , Immunophenotyping , Lymphocyte Culture Test, Mixed , Male , Middle Aged , Scleroderma, Systemic/therapy
6.
J Cell Sci ; 117(Pt 4): 571-81, 2004 Feb 01.
Article in English | MEDLINE | ID: mdl-14709716

ABSTRACT

We cloned and characterized a novel member of the tenascin family of extracellular matrix proteins--the murine orthologue of zebrafish tenascin-W. Full-length recombinant tenascin-W was expressed and purified from mammalian cell cultures. Rotary shadowing followed by electron microscopy showed that tenascin-W forms hexabrachions. We studied its expression during development and in the adult by immunohistochemistry, in situ hybridization and immunoblotting. Tenascin-W is expressed during palate formation, osteogenesis and smooth muscle development. In the adult, tenascin-W is found in the kidney, cardiac semilunar valves, corneal limbus and periosteum. Tenascin-W and tenascin-C expression overlap in many of these areas. Bone-morphogenic-protein-2 treated C2C12 cells secrete tenascin-W and are able to adhere to and to extend actin-rich processes on a tenascin-W substratum. In vitro, cells bind to tenascin-W in an RGD-dependent manner. This adhesion is increased by transfection of alpha8 integrin, which localizes with tenascin-W in the periosteum and kidney.


Subject(s)
Bone and Bones/metabolism , Gene Expression Regulation, Developmental , Kidney/metabolism , Muscle, Smooth/metabolism , Tenascin/genetics , Amino Acid Sequence , Animals , Bone and Bones/embryology , Cell Adhesion/physiology , Cells, Cultured , Cloning, Molecular , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , Humans , Immunohistochemistry , In Situ Hybridization , Kidney/embryology , Mice , Molecular Sequence Data , Muscle, Smooth/embryology , Organ Specificity , Phylogeny , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Tenascin/analogs & derivatives , Tenascin/biosynthesis , Tenascin/isolation & purification , Zebrafish , Zebrafish Proteins/genetics
7.
Therapie ; 55(1): 35-41, 2000.
Article in English | MEDLINE | ID: mdl-10859999

ABSTRACT

Experimental models based on the culture of cells within tridimensional (3-D) gels add a 3-D organization to the classical 2-D culture of vascular cells. They allow the study of cell structure in an environment which is more representative of the in vivo situation and the investigation of cellular functions which cannot be studied using the basic 2-D models. This review shows examples of the use of cultures of vascular cells (endothelial cells, smooth muscle cells as well as fibroblasts) in 3-D collagen matrices for the study of cellular functions as diverse as angiogenesis, extracellular matrix reorganization, migration through 3-D collagen gels or phenotype modulation. It also describes recent advances in the in vitro reconstruction of biological blood vessels by bioengineering. A method for the preparation of 3-D collagen gels is described.


Subject(s)
Collagen , Cytological Techniques , Muscle, Smooth, Vascular/cytology , Cells, Cultured , Culture Media , Humans
8.
J Cell Sci ; 113 ( Pt 4): 653-62, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10652258

ABSTRACT

Migration of vascular smooth muscle cells (VSMC) is a key event in the formation of neointima during atherosclerosis. Fura-2 loaded VSMCs were used to investigate calcium homeostasis during cell migration. Multiple spontaneous transient increases in cytosolic free calcium [Ca(2+)](i)were observed in single human VSMCs migrating on type I collagen. Such [Ca(2+)](i)transients were dependent on the presence of serum or PDGF-BB. Removal of serum, or loading cells with BAPTA, abolished the transients and decreased cell migration speed. The transients were not affected by disruption of cell polarization by dihydrocytochalasin B. Adhesion was used to investigate the specific role of cell-substrate interactions in the generation of transients. Transients are seen in VSMCs adhering either on collagen or on poly-L-lysine, suggesting that generation of transients is not strictly dependent on integrins. Buffering [Ca(2+)](i) with BAPTA led to accumulation of (beta)1 integrins at the cellular tail, and to increased release of integrin on the extracellular matrix. These results demonstrate a role for [Ca(2+)](i) transients in the rapid, serum-dependent migration of VSMCs. These [Ca(2+)](i)transients are present in migrating VSMCs only when two simultaneous events occur: (1) substrate independent spreading and (2) stimulation of cells by serum components such as PDGF-BB.


Subject(s)
Blood Proteins/pharmacology , Calcium/metabolism , Cell Movement/physiology , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/metabolism , Antibodies, Monoclonal/pharmacology , Anticoagulants/pharmacology , Becaplermin , Buffers , Cell Adhesion/drug effects , Cell Movement/drug effects , Cell Size/drug effects , Cells, Cultured , Chelating Agents/pharmacology , Collagen/pharmacology , Cytochalasin B/analogs & derivatives , Cytochalasin B/pharmacology , Cytosol/metabolism , Dose-Response Relationship, Drug , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Flow Cytometry , Humans , Image Processing, Computer-Assisted , Integrin beta1/analysis , Integrin beta1/immunology , Mammary Arteries/cytology , Muscle, Smooth, Vascular/chemistry , Platelet-Derived Growth Factor/pharmacology , Proto-Oncogene Proteins c-sis
9.
Arterioscler Thromb Vasc Biol ; 18(11): 1691-7, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9812906

ABSTRACT

CD9, a member of the tetraspanin family, and very late-acting (VLA) integrins are known to associate and form functional units on the surface of several cell types. We studied the changes in expression of CD9 and beta1-integrins (CD29, VLA) in human vascular smooth muscle cells (VSMCs) under in vitro culture conditions mimicking proliferative vascular diseases. We also investigated possible interactions between CD9 and VLA integrins in VSMCs. We found that CD9 is highly expressed in VSMCs and is subject to modulation, depending on the proliferative/contractile state of the cells. In the contractile phenotype, the levels of CD9, CD81, another tetraspanin, and CD29 are approximately 50% of those found in the proliferative phenotype. Coimmunoprecipitation experiments showed physical association between CD9 and CD29. CD9 was mainly associated with alpha2 and alpha3-integrins (CD49b and c) and also with alpha5-integrin to a weaker extent. Functionally, the addition of anti-CD9 monoclonal antibodies (MoAbs) doubled the extent of collagen gel contraction mediated by VSMCs, a model for the reorganization of the extracellular collagen matrix occurring in the vessel wall. Anti-CD29 MoAbs inhibited gel contraction, but anti-CD9 MoAbs counteracted this inhibitory effect of anti-CD29 MoAbs. Transfection of human CD9 into Chinese hamster ovary cells more than doubled the extent of Chinese hamster ovary cell-mediated collagen gel contraction (130% stimulation), confirming a role for CD9 in extracellular matrix reorganization. Thus, CD9 seems to be involved in the modulation of VLA integrin-mediated collagen matrix reorganization by VSMCs. These findings suggest that high CD9 expression is associated with a proliferative state of VSMCs. The role of CD9 could be to modulate the function of VLA integrins on the surface of VSMCs.


Subject(s)
Antigens, CD/analysis , Collagen/ultrastructure , Integrin beta1/analysis , Membrane Glycoproteins , Muscle, Smooth, Vascular/chemistry , Receptors, Very Late Antigen/analysis , Animals , Antibodies, Monoclonal , CHO Cells , Cell Division/physiology , Cells, Cultured , Cricetinae , Humans , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/immunology , Phenotype , Precipitin Tests , Tetraspanin 29 , Transfection , Vasoconstriction/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...